CLASS II Drug recall · Reported 12 Dec 2012 · FDA Enforcement Report
Levothroid (levothyroxine sodium tablets, USP),125 mcg recalled
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium tablets, USP),125 mcg, distributed nationwide in the US. The recall was initiated on 9 Jul 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-081-2013
- FDA event ID
- 62511
- Recalling firm
- Lloyd Inc. of Iowa, Shenandoah, IA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 9 Jul 2012
- FDA classified
- 3 Dec 2012
- Reported
- 12 Dec 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Telephone
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Thyroid Medication
Timeline
| 9 Jul 2012 | Recall initiated by company | |
| 3 Dec 2012 | Classified by FDA | +147 days |
| 12 Dec 2012 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP Deviations; does not meet in process specification requirements
Product as listed by the FDA
Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Where it was distributed
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Questions about this recall
Is Levothroid (levothyroxine sodium tablets, USP),125 mcg recalled?
Yes. Lloyd Inc. of Iowa recalled Levothroid (levothyroxine sodium tablets, USP),125 mcg on 9 Jul 2012. The recall is Class II and its status is Terminated. Recall number D-081-2013.
Why was it recalled?
cGMP Deviations; does not meet in process specification requirements
Which lots are affected?
Lot #1095210, exp. 4/30/2013
Where was it sold?
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Lloyd Inc. of Iowa
All 36| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lloyd Thyro-Tab 200 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP), 175 mcg recalled | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Lloyd Thyro-Tab 175 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Lloyd Thyro-Tab 137 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP) , 125 mcg recalled | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |